Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""C. C. Coutant"" wg kryterium: Autor


Tytuł :
Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort .
Autorzy :
Houvenaeghel G; Department of Surgical Oncology, CRCM, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, INSERM, Marseille, France. Electronic address: .
de Nonneville A; Department of Medical Oncology, CRCM, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, INSERM, Marseille, France.
Cohen M; Department of Surgical Oncology, CRCM, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, INSERM, Marseille, France.
Chopin N; Department of Surgical Oncology, Centre Léon Bérard, Lyon, France.
Coutant C; Department of Surgical Oncology, Centre Georges François Leclerc, Dijon, France.
Reyal F; Department of Surgical Oncology, Institut Curie, Paris Cedex 05, Paris, France.
Mazouni C; Department of Surgical Oncology, Institut Gustave Roussy, Villejuif, France.
Gimbergues P; Department of Surgical Oncology, Centre Jean Perrin, Clermont Ferrand, France.
Azuar AS; Department of Surgical Oncology, Hôpital de Grasse, Grasse, France.
Chauvet MP; Department of Surgical Oncology, Centre Oscar Lambret, Lille, France.
Classe JM; Department of Surgical Oncology, Institut René Gauducheau, St Herblain, France.
Daraï E; Department of Surgical Oncology, Hôpital Tenon, Paris, France.
Martinez A; Department of Surgical Oncology, Centre Claudius Regaud, Toulouse, France.
Rouzier R; Department of Surgical Oncology, Hôpital René Huguenin, Saint Cloud, France.
de Lara CT; Department of Surgical Oncology, Institut Bergonié, Bordeaux, France.
Lambaudie E; Department of Surgical Oncology, CRCM, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, INSERM, Marseille, France.
Barrou J; Department of Surgical Oncology, CRCM, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, INSERM, Marseille, France.
Goncalves A; Department of Medical Oncology, CRCM, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, INSERM, Marseille, France.
Pokaż więcej
Źródło :
ESMO open [ESMO Open] 2021 Jun; Vol. 6 (3), pp. 100151. Date of Electronic Publication: 2021 May 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France.
Autorzy :
Blay JY; Centre Leon Berard, Lyon, France. Electronic address: .
Boucher S; Unicancer, Paris, France.
Le Vu B; Unicancer, Paris, France.
Cropet C; Centre Leon Berard, Lyon, France.
Chabaud S; Centre Leon Berard, Lyon, France.
Perol D; Centre Leon Berard, Lyon, France.
Barranger E; Centre Antoine Lacassagne, Nice, France.
Campone M; Institut de Cancerologie de l'Ouest, Nantes et Angers, France.
Conroy T; Institut de Cancerologie de Lorraine, Nancy, France.
Coutant C; Centre George Francoise Leclerc, Dijon, France.
De Crevoisier R; Centre Eugene Marquis, Rennes, France.
Debreuve-Theresette A; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
Delord JP; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
Fumoleau P; Institut Curie, Paris, France.
Gentil J; Centre George Francoise Leclerc, Dijon, France.
Gomez F; Centre Leon Berard, Lyon, France.
Guerin O; Institut de Cancerologie de l'Ouest, Nantes et Angers, France.
Jaffré A; Institut Bergonié, Bordeaux.
Lartigau E; Centre Oscar Lambret, Lille, France.
Lemoine C; Institut Paoli-Calmettes, Marseille, France.
Mahe MA; Centre François Baclesse, Caen, France.
Mahon FX; Institut Bergonié, Bordeaux.
Mathieu-Daude H; Institut de Cancerologie de Montpellier, Montpellier, France.
Merrouche Y; Institut Jean Godinot, Reims, France.
Penault-Llorca F; Centre Jean Perrin, Clermont Ferrand, France.
Pivot X; Centre Paul Strauss/ICANS, Strasbourg, France.
Soria JC; Gustave Roussy, Villejuif, France.
Thomas G; Centre François Baclesse, Caen, France.
Vera P; Centre Henri Becquerel, Rouen, France.
Vermeulin T; Centre Henri Becquerel, Rouen, France.
Viens P; Institut Paoli-Calmettes, Marseille, France.
Ychou M; Institut de Cancerologie de Montpellier, Montpellier, France.
Beaupere S; Unicancer, Paris, France.
Pokaż więcej
Źródło :
ESMO open [ESMO Open] 2021 Jun; Vol. 6 (3), pp. 100134. Date of Electronic Publication: 2021 Apr 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/complications
Neoplasms/*complications
Female ; France ; Humans ; Male ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Incidental findings in a series of 2500 gene panel tests for a genetic predisposition to cancer: Results and impact on patients.
Autorzy :
Nambot S; Centre de Génétique, FHU TRANSLAD, Institut GIMI, CHU Dijon, F-21000, Dijon, France; CGFL, Unité D'oncogénétique et Institut GIMI, F-21000, Dijon, France. Electronic address: .
Sawka C; Centre de Génétique, FHU TRANSLAD, Institut GIMI, CHU Dijon, F-21000, Dijon, France; CGFL, Unité D'oncogénétique et Institut GIMI, F-21000, Dijon, France.
Bertolone G; Centre de Génétique, FHU TRANSLAD, Institut GIMI, CHU Dijon, F-21000, Dijon, France; CGFL, Unité D'oncogénétique et Institut GIMI, F-21000, Dijon, France.
Cosset E; CGFL, Unité D'oncogénétique et Institut GIMI, F-21000, Dijon, France.
Goussot V; Platform of Transfer in Cancer Biology, Department of Biology and Pathology of Tumours, Centre Georges-François Leclerc, Unicancer, F-21000, Dijon, France.
Derangère V; Platform of Transfer in Cancer Biology, Department of Biology and Pathology of Tumours, Centre Georges-François Leclerc, Unicancer, F-21000, Dijon, France.
Boidot R; Platform of Transfer in Cancer Biology, Department of Biology and Pathology of Tumours, Centre Georges-François Leclerc, Unicancer, F-21000, Dijon, France; CNRS, 6302 Unit, Dijon, France.
Baurand A; Centre de Génétique, FHU TRANSLAD, Institut GIMI, CHU Dijon, F-21000, Dijon, France; CGFL, Unité D'oncogénétique et Institut GIMI, F-21000, Dijon, France.
Robert M; Centre de Génétique, FHU TRANSLAD, Institut GIMI, CHU Dijon, F-21000, Dijon, France.
Coutant C; Département de Chirurgie, Centre Georges François Leclerc, F-21000, Dijon, France.
Loustalot C; Département de Chirurgie, Centre Georges François Leclerc, F-21000, Dijon, France.
Thauvin-Robinet C; Centre de Génétique, FHU TRANSLAD, Institut GIMI, CHU Dijon, F-21000, Dijon, France.
Ghiringhelli F; Platform of Transfer in Cancer Biology, Department of Biology and Pathology of Tumours, Centre Georges-François Leclerc, Unicancer, F-21000, Dijon, France; Département D'oncologie Médicale, Centre Georges François Leclerc, Dijon, France; Centre de Recherche INSERM LNC-UMR123, Université de Bourgogne Franche-Comté, F-21000, Dijon, France.
Lançon A; CGFL, Unité D'oncogénétique et Institut GIMI, F-21000, Dijon, France.
Populaire C; Service Génétique et Biologie Du Développement-Histologie, CHU Hôpital Saint-Jacques, Besançon, France.
Damette A; Service Génétique et Biologie Du Développement-Histologie, CHU Hôpital Saint-Jacques, Besançon, France.
Collonge-Rame MA; Service Génétique et Biologie Du Développement-Histologie, CHU Hôpital Saint-Jacques, Besançon, France.
Meunier-Beillard N; INSERM, CIC1432, Module épidémiologie Clinique, Dijon, France; Centre Hospitalier Universitaire Dijon-Bourgogne, Centre D'investigation Clinique, Module épidémiologie Clinique/essais Cliniques, Dijon, France.
Lejeune C; Centre de Recherche INSERM LNC-UMR123, Université de Bourgogne Franche-Comté, F-21000, Dijon, France; INSERM, CIC1432, Module épidémiologie Clinique, Dijon, France; Centre Hospitalier Universitaire Dijon-Bourgogne, Centre D'investigation Clinique, Module épidémiologie Clinique/essais Cliniques, Dijon, France.
Albuisson J; Platform of Transfer in Cancer Biology, Department of Biology and Pathology of Tumours, Centre Georges-François Leclerc, Unicancer, F-21000, Dijon, France; Centre de Recherche INSERM LNC-UMR123, Université de Bourgogne Franche-Comté, F-21000, Dijon, France.
Faivre L; Centre de Génétique, FHU TRANSLAD, Institut GIMI, CHU Dijon, F-21000, Dijon, France; CGFL, Unité D'oncogénétique et Institut GIMI, F-21000, Dijon, France. Electronic address: .
Pokaż więcej
Źródło :
European journal of medical genetics [Eur J Med Genet] 2021 May; Vol. 64 (5), pp. 104196. Date of Electronic Publication: 2021 Mar 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Management of borderline ovarian tumours during pregnancy: Results of a French multi-centre study.
Autorzy :
Zilliox M; Department of Gynaecology, University Hospital of Hautepierre, Strasbourg, France. Electronic address: .
Lecointre L; Department of Gynaecology, University Hospital of Hautepierre, Strasbourg, France; I-Cube UMR 7357 Science Laboratory, Strasbourg, France; IHU: Institute for Minimally Invasive Hybrid Image Guided Surgery, Strasbourg, France.
Azais H; Department of Gynaecology, Pitié Salpetriere Hospital, Paris, France.
Ballester M; Department of Gynaecology, Diaconesses Croix Saint Simon, Paris, France.
Bendifallah S; Department of Gynaecology, Tenon Hospital, Paris, France.
Bolze PA; Department of Gynaecology, University Hospital South Lyon, Pierre-Bénite, France.
Bourdel N; Department of Gynaecology, University Hospital of Clermont Ferrand, Clermont Ferrand, France.
Bricou A; Department of Gynaecology, Diaconesses Croix Saint Simon, Paris, France.
Canlorbe G; Department of Gynaecology, Pitié Salpetriere Hospital, Paris, France.
Carcopino X; Department of Gynaecology, La Timone Hospital, Marseille, France.
Chauvet P; Department of Gynaecology, University Hospital of Clermont Ferrand, Clermont Ferrand, France.
Collinet P; Department of Gynaecology, Jeanne de Flandres Hospital, Lille, France.
Coutant C; Centre de Lutte Contre le Cancer, Dijon, France.
Dabi Y; Department of Gynaecology, Tenon Hospital, Paris, France.
Dion L; Department of Gynaecology, University South Hospital, Rennes, France.
Gauthier T; Department of Gynaecology, University Hospital, Limoges, France.
Graesslin O; Department of Gynaecology, University Hospital, Reims, France.
Huchon C; Department of Gynaecology, Intercommunal Hospital of Poissy, Poissy, France.
Koskas M; Department of Gynaecology, Bichat Hospital, Paris, France.
Lavoue V; Department of Gynaecology, University South Hospital, Rennes, France.
Mezzadri M; Department of Gynaecology, Lariboisière Hospital, Paris, France.
Mimoun C; Department of Gynaecology, Lariboisière Hospital, Paris, France.
Ouldamer L; Department of Gynaecology, University Hospital of Tours, Tours, France.
Raimond E; Department of Gynaecology, University Hospital, Reims, France.
Touboul C; Department of Gynaecology, Tenon Hospital, Paris, France.
Lapointe M; Department of Gynaecology, University Hospital of Hautepierre, Strasbourg, France.
Akladios C; Department of Gynaecology, University Hospital of Hautepierre, Strasbourg, France.
Pokaż więcej
Źródło :
European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2021 Jan; Vol. 256, pp. 412-418. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Laparoscopy*
Ovarian Neoplasms*/diagnostic imaging
Ovarian Neoplasms*/surgery
Child ; Cystectomy ; Female ; Humans ; Multicenter Studies as Topic ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Pregnancy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Prognostic Value and Risk Factors of Peritoneal Carcinomatosis Recurrence for Patients with Endometrial Cancer: A Multicenter Study from the FRANCOGYN Group.
Autorzy :
Gaudet Chardonnet A; AP-HP (Assistance Publique des Hôpitaux de Paris), Department of Gynecological and Breast Surgery and Oncology, Pitié-Salpêtrière University Hospital, Paris, France.
Azaïs H; AP-HP (Assistance Publique des Hôpitaux de Paris), Department of Gynecological and Breast Surgery and Oncology, Pitié-Salpêtrière University Hospital, Paris, France.
Ballester M; Service de Chirurgie Gynécologique et Mammaire, Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, France.
Raimond E; Department of Obstetrics and Gynaecology, Institute Alix de Champagne University Hospital, Reims, France.
Bendifallah S; AP-HP (Assistance Publique des Hôpitaux de Paris), Department of Gynaecology and Obstetrics, Tenon University Hospital, Paris, France.; INSERM UMR_S_938, 'Cancer Biology and Therapeutics,' Centre de Recherche Saint-Antoine (CRSA), Sorbonne University, Paris, France.; Institut Universitaire de Cancérologie (IUC), Sorbonne University, Paris, France.
Ouldamer L; Department of Obstetrics and Gynaecology, Centre Hospitalier Régional Universitaire de Tours, Tours, France.
Coutant C; Center de Lutte Contre le Cancer Georges François Leclerc, Dijon, France.
Graesslin O; Department of Obstetrics and Gynaecology, Institute Alix de Champagne University Hospital, Reims, France.
Touboul C; Department of Obstetrics and Gynaecology, Centre Hospitalier Intercommunal, Créteil, France.
Collinet P; Department of Obstetrics and Gynaecology, Centre Hospitalier Intercommunal, Créteil, France.; Department of Obstetrics and Gynaecology, Centre Hospitalier Régional Universitaire, Lille, France.
Bricou A; AP-HP (Assistance Publique des Hôpitaux de Paris), Department of Gynaecology and Obstetrics, Jean Verdier University Hospital, Bondy, France.
Huchon C; Department of Gynaecology and Obstetrics, Centre Hospitalier Intercommunal, Poissy, France.
Daraï E; AP-HP (Assistance Publique des Hôpitaux de Paris), Department of Gynaecology and Obstetrics, Tenon University Hospital, Paris, France.; INSERM UMR_S_938, 'Cancer Biology and Therapeutics,' Centre de Recherche Saint-Antoine (CRSA), Sorbonne University, Paris, France.; Institut Universitaire de Cancérologie (IUC), Sorbonne University, Paris, France.
Lavoue V; Service de Gynécologie, INSERM 1242, Oncogenesis, Stress and Signaling, CRLC Eugène Marquis, Université de Rennes 1, Hopital Sud, CHU de Rennes, Rennes, France.
Koskas M; Service de Chirurgie et Oncologie Gynécologique et Mammaire, APHP, Université Paris Diderot Hôpital Bichat, Paris, France.
Uzan C; AP-HP (Assistance Publique des Hôpitaux de Paris), Department of Gynecological and Breast Surgery and Oncology, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMR_S_938, 'Cancer Biology and Therapeutics,' Centre de Recherche Saint-Antoine (CRSA), Sorbonne University, Paris, France.; Institut Universitaire de Cancérologie (IUC), Sorbonne University, Paris, France.
Canlorbe G; AP-HP (Assistance Publique des Hôpitaux de Paris), Department of Gynecological and Breast Surgery and Oncology, Pitié-Salpêtrière University Hospital, Paris, France. .; INSERM UMR_S_938, 'Cancer Biology and Therapeutics,' Centre de Recherche Saint-Antoine (CRSA), Sorbonne University, Paris, France. .; Institut Universitaire de Cancérologie (IUC), Sorbonne University, Paris, France. .
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2021 Jan; Vol. 28 (1), pp. 212-221. Date of Electronic Publication: 2020 Jul 09.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Endometrial Neoplasms*/pathology
Peritoneal Neoplasms*
Female ; Humans ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Prognosis ; Prospective Studies ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
[Comparing prediction performances of F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after neoadjuvant chemotherapy for HER2-positive breast cancers].
Autorzy :
Vincent L; Département de chirurgie oncologique, centre Georges-François-Leclerc, 1, rue du Professeur-Marion, 21000 Dijon, France. Electronic address: .
Jankowski C; Département de chirurgie oncologique, centre Georges-François-Leclerc, 1, rue du Professeur-Marion, 21000 Dijon, France.
Arnould L; Département de biologie et pathologie des tumeurs, centre Georges-François-Leclerc, 1, rue du Professeur-Marion, 21000 Dijon, France.
Coudert B; Département d'oncologie médicale, centre Georges-François-Leclerc, 1, rue du Professeur-Marion, 21000 Dijon, France.
Rouzier R; Département de chirurgie oncologique, institut Curie, 26, rue d'Ulm, 75005 Paris, France.
Reyal F; Département de chirurgie oncologique, institut Curie, 26, rue d'Ulm, 75005 Paris, France.
Humbert O; Département de médecine nucléaire, centre Georges-François-Leclerc, 1, rue du Professeur-Marion, 21000 Dijon, France.
Coutant C; Département de chirurgie oncologique, centre Georges-François-Leclerc, 1, rue du Professeur-Marion, 21000 Dijon, France; ImVia, UFR des sciences de santé, 7, boulevard Jeanne-d'Arc, 21000 Dijon, France.
Pokaż więcej
Transliterated Title :
Comparaison des performances prédictives du TEP-TDM et du nomogramme CGFL/Curie pour prédire la réponse histologique complète après chimiothérapie néo-adjuvante des cancers du sein HER2-positifs.
Źródło :
Gynecologie, obstetrique, fertilite & senologie [Gynecol Obstet Fertil Senol] 2020 Sep; Vol. 48 (9), pp. 679-686. Date of Electronic Publication: 2020 Mar 20.
Typ publikacji :
English Abstract; Journal Article
Czasopismo naukowe
Tytuł :
Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study group.
Autorzy :
Vincent L; Department of Surgical Oncology, Georges-Francois Leclerc Cancer Center, 1 Professeur Marion Street, 21000, Dijon, France; University of Burgundy, 7 Jeanne d'Arc boulevard, 21000, Dijon, France. Electronic address: .
Jankowski C; Department of Surgical Oncology, Georges-Francois Leclerc Cancer Center, 1 Professeur Marion Street, 21000, Dijon, France.
Ouldamer L; Department of Gynecology, Centre Hospitalier Universitaire de Tours, 2 Tonnelé boulevard, 37000, Tours, France; INSERM U1069 Université François-Rabelais, 10 Tonnelé boulevard, 37000, Tours, France.
Ballester M; Department of Gynecologic and Breast Surgery, Groupe Hospitalier Diaconesses Croix Saint Simon, 125 Avron Street, 75020, Paris, France.
Bendifallah S; Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), 4 Chine street, 75020, Paris, France.
Bolze PA; Gynecological Surgery Service, CHU Lyon-Sud, 165 Grand Revoyet Road, 69495, Pierre-Bénite, France.
Akladios C; Department of Surgical Gynecology, University Hospital of Strasbourg, Molière Avenue, 67200, Strasbourg, France.
Costaz H; Department of Surgical Oncology, Georges-Francois Leclerc Cancer Center, 1 Professeur Marion Street, 21000, Dijon, France.
Lavoué V; Department of Gynecological Surgery, Rennes University Hospital, 16 Bulgarie boulevard, 35200, Rennes, France.
Canlorbe G; Department of Gynecologic and Breast Surgery and Oncology, AP-HP, Pitié-Salpêtrière University Hospital, 47-83 Hopital boulevard, 75013, Paris, France; INSERM,UMR S 938, Sorbonne University, 75005, Paris, France.
Collinet P; Department of Gynecological Surgery, Jeanne de Flandre University Hospital, Eugéne Avinée Avenue, 59000, Lille, France.
Touboul C; Department of Obstetrics and Gynaecology, Centre Hospitalier Intercommunal, 40 Verdun Avenue, 94010, Créteil, France.
Huchon C; Department of Gynecology, Centre Hospitalier de Poissy, 10 Champ Gaillard Street, 78300, Poissy, France.
Bricou A; Department of Gynaecology, Bobigny University, AP-HP, Hôpital Jean-Verdier, 14 Juillet Avenue, 93140, Bondy, France.
Dridi S; Department of Surgical Oncology, Georges-Francois Leclerc Cancer Center, 1 Professeur Marion Street, 21000, Dijon, France; University of Burgundy, 7 Jeanne d'Arc boulevard, 21000, Dijon, France.
Padéano MM; Department of Surgical Oncology, Georges-Francois Leclerc Cancer Center, 1 Professeur Marion Street, 21000, Dijon, France.
Bengrine L; Department of Medical Oncology, Georges-Francois Leclerc Cancer Center, Dijon, 1 Professeur Marion Street, 21000, France.
Arnould L; Department of Anatomopathology, Georges-Francois Leclerc Cancer Center, 1 Professeur Marion Street, 21000, Dijon, France.
Coutant C; Department of Surgical Oncology, Georges-Francois Leclerc Cancer Center, 1 Professeur Marion Street, 21000, Dijon, France; University of Burgundy, 7 Jeanne d'Arc boulevard, 21000, Dijon, France.
Pokaż więcej
Corporate Authors :
Groupe de Recherche FRANCOGYN
Źródło :
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2020 Sep; Vol. 46 (9), pp. 1689-1696. Date of Electronic Publication: 2020 Apr 24.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Cytoreduction Surgical Procedures*
Neoadjuvant Therapy*
Antineoplastic Agents/*therapeutic use
Carcinoma, Ovarian Epithelial/*therapy
Lymph Node Excision/*statistics & numerical data
Lymph Nodes/*pathology
Ovarian Neoplasms/*therapy
Aged ; Ascitic Fluid/pathology ; Carcinoma, Ovarian Epithelial/genetics ; Carcinoma, Ovarian Epithelial/pathology ; Cohort Studies ; Female ; France ; Genes, BRCA1 ; Genes, BRCA2 ; Humans ; Lymph Nodes/surgery ; Middle Aged ; Multivariate Analysis ; Neoplasm Invasiveness ; Neoplasm Staging ; Neoplasm, Residual ; Omentum/pathology ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology ; Pelvis ; Peritoneal Lavage ; Platinum Compounds/therapeutic use ; Prognosis ; Proportional Hazards Models ; Survival Rate ; Taxoids/therapeutic use
Czasopismo naukowe
Tytuł :
[Guidelines for surgical management of gynaecological cancer during pandemic COVID-19 period - FRANCOGYN group for the CNGOF].
Autorzy :
Akladios C; Service de gynécologie, CHU de Hautepierre, 67000 Strasbourg, France.
Azais H; Service de gynécologie, hôpital la Pitié-Salpêtrière, 75013 Paris, France.
Ballester M; Service de gynécologie, Dioconessess Croix Saint Simon, 75012 Paris, France.
Bendifallah S; Service de gynécologie obstétrique, hôpital Tenon, 75020 Paris, France.
Bolze PA; Service de gynécologie obstétrique, CHU Lyon Sud, 69000 Lyon, France.
Bourdel N; Service de gynécologie obstétrique, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France.
Bricou A; Service de gynécologie, Dioconessess Croix Saint Simon, 75012 Paris, France.
Canlorbe G; Service de gynécologie, hôpital la Pitié-Salpêtrière, 75013 Paris, France.
Carcopino X; Service de gyécologie, La Timone, 13000 Marseille, France.
Chauvet P; Service de gynécologie obstétrique, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France.
Collinet P; Service de gynécologie, hôpital Jeanne de Flandres, 59000 Lille, France.
Coutant C; Centre de lutte contre le cancer, 21000 Dijon, France.
Dabi Y; Service de gynécologie obstétrique, hôpital Tenon, 75020 Paris, France.
Dion L; Service de gynécologie, CHU hôpital Sud, 16, boulevard de Bulgarie, 35000 Rennes, France.
Gauthier T; Service de gynécologie obstétrique, CHU, 87000 Limoges, France.
Graesslin O; Service de gynécologie obstétrique, CHU, 51000 Reims, France.
Huchon C; Service de gynécologie obstétrique, CHI Poissy, 78300 Poissy, France.
Koskas M; Service de gynécologie obstétrique, hôpital Bichat, 75018 Paris, France.
Kridelka F; Service de chirurgie oncologique, CHU, Liège, Belgique.
Lavoue V; Service de gynécologie, CHU hôpital Sud, 16, boulevard de Bulgarie, 35000 Rennes, France. Electronic address: .
Lecointre L; Service de gynécologie obstétrique, hôpital Tenon, 75020 Paris, France.
Mezzadri M; Service de gynécologie, hôpital Lariboisière, 75010 Paris, France.
Mimoun C; Service de gynécologie, hôpital Lariboisière, 75010 Paris, France.
Ouldamer L; Service de gynécologie, CHU Tours, 37000 Tours, France.
Raimond E; Service de gynécologie obstétrique, CHU, 51000 Reims, France.
Touboul C; Service de chirurgie oncologique, CHU, Liège, Belgique.
Pokaż więcej
Transliterated Title :
Prise en charge chirurgicale des cancers gynécologiques en période de pandémie COVID-19 – Recommandations du Groupe FRANCOGYN pour le CNGOF.
Źródło :
Gynecologie, obstetrique, fertilite & senologie [Gynecol Obstet Fertil Senol] 2020 May; Vol. 48 (5), pp. 444-447. Date of Electronic Publication: 2020 Mar 25.
Typ publikacji :
Journal Article
MeSH Terms :
Betacoronavirus*
Gynecologic Surgical Procedures*/adverse effects
Coronavirus Infections/*complications
Genital Neoplasms, Female/*surgery
Pneumonia, Viral/*complications
COVID-19 ; Coronavirus Infections/transmission ; Cytoreduction Surgical Procedures ; Female ; France ; Genital Neoplasms, Female/complications ; Humans ; Minimally Invasive Surgical Procedures ; Pandemics ; Pneumonia, Viral/transmission ; Practice Guidelines as Topic ; SARS-CoV-2 ; Societies, Medical
Czasopismo naukowe
Tytuł :
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Autorzy :
Ferreira AR; INSERM Unit 981, Gustave Roussy, Cancer Campus, Villejuif, France; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
Di Meglio A; INSERM Unit 981, Gustave Roussy, Cancer Campus, Villejuif, France.
Pistilli B; Medical Oncology, Gustave Roussy, Cancer Campus, Villejuif.
Gbenou AS; INSERM Unit 981, Gustave Roussy, Cancer Campus, Villejuif, France.
El-Mouhebb M; INSERM Unit 981, Gustave Roussy, Cancer Campus, Villejuif, France.
Dauchy S; Department of Supportive Care, Gustave Roussy, Cancer Campus, Villejuif.
Charles C; Department of Supportive Care, Gustave Roussy, Cancer Campus, Villejuif.
Joly F; Medical Oncology, Centre François Baclesse Caen, Caen.
Everhard S; Unicancer, Paris, France.
Lambertini M; Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.
Coutant C; Surgical Oncology, Centre Georges-François Leclerc, Dijon.
Cottu P; Medical Oncology, Institut Curie, Paris.
Lerebours F; Medical Oncology, Institut Curie, Hôpital René Huguenin, Saint-Cloud.
Petit T; Department of Medicine, Paul Strauss Cancer Center and University of Strasbourg, Strasbourg.
Dalenc F; Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer - Oncopole, Toulouse.
Rouanet P; Surgical Oncology, C.R.L.C Val d'Aurelle, Montpellier.
Arnaud A; Radiotherapy Department, Clinique Sainte Catherine Avignon, Avignon.
Martin A; Unicancer, Paris, France.
Berille J; Ministry of Higher Education and Research, Ministere de l'Enseignement Superieur et de la Recherche, Paris, France.
Ganz PA; Medical Oncology, Ronald Reagan UCLA Medical Center, Los Angeles.
Partridge AH; Women's Cancers, Dana-Farber Cancer Institute, Boston, USA.
Delaloge S; Medical Oncology, Gustave Roussy, Cancer Campus, Villejuif.
Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, University Paris-Sud, University Paris-Saclay, Villejuif; CESP, INSERM, U1018 ONCOSTAT, Université Paris-Saclay, Univ. Paris-Sud, Villejuif, France.
Andre F; INSERM Unit 981, Gustave Roussy, Cancer Campus, Villejuif, France; Medical Oncology, Gustave Roussy, Cancer Campus, Villejuif.
Vaz-Luis I; INSERM Unit 981, Gustave Roussy, Cancer Campus, Villejuif, France; Medical Oncology, Gustave Roussy, Cancer Campus, Villejuif. Electronic address: .
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Nov 01; Vol. 30 (11), pp. 1784-1795.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Quality of Life*
Antibiotics, Antineoplastic/*adverse effects
Antineoplastic Agents, Hormonal/*adverse effects
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Breast Neoplasms/*therapy
Cancer Survivors/*statistics & numerical data
Adult ; Aged ; Breast/pathology ; Breast/surgery ; Breast Neoplasms/pathology ; Chemotherapy, Adjuvant/adverse effects ; Chemotherapy, Adjuvant/methods ; Female ; Humans ; Longitudinal Studies ; Middle Aged ; Patient Reported Outcome Measures ; Patient Selection ; Prospective Studies ; Surveys and Questionnaires/statistics & numerical data
Czasopismo naukowe
Tytuł :
Patterns of care and the survival of elderly patients with high-risk endometrial cancer: A case-control study from the FRANCOGYN group.
Autorzy :
Rousselin A; CHU de Rennes, Service de Gynécologie, Hopital Sud, 16 Bd de Bulgarie, 35000 Rennes, France; Université de Rennes 1, France; INSERM 1242, Oncogenesis, Stress and Signaling, CRLC Eugène Marquis, Rennes, France.
Bendifallah S; Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), University Pierre and Marie Curie, Institut Universitaire de Cancérologie (IUC), Paris 6, France; INSERM UMR_S_707, 'Epidemiology, Information Systems, Modeling', University Pierre and Marie Curie, Paris 6, France.
Nyangoh Timoh K; CHU de Rennes, Service de Gynécologie, Hopital Sud, 16 Bd de Bulgarie, 35000 Rennes, France; Université de Rennes 1, France; INSERM 1242, Oncogenesis, Stress and Signaling, CRLC Eugène Marquis, Rennes, France.
Ouldamer L; Department of Obstetrics and Gynaecology, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, Tours, France.
Canlorbe G; Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), University Pierre and Marie Curie, Institut Universitaire de Cancérologie (IUC), Paris 6, France.
Raimond E; Department of Obstetrics and Gynaecology, Institute Alix de Champagne University Hospital, Reims, France.
Hudry N; Center de lutte contre le cancer Georges François Leclerc, Dijon, France.
Coutant C; Center de lutte contre le cancer Georges François Leclerc, Dijon, France.
Graesslin O; Department of Obstetrics and Gynaecology, Institute Alix de Champagne University Hospital, Reims, France.
Touboul C; Department of Obstetrics and Gynaecology, Centre Hospitalier Intercommunal, Créteil, France.
Collinet P; Department of Obstetrics and Gynaecology, Centre Hospitalier Régional Universitaire, Lille, France.
Bricou A; Department of Gynaecology and Obstetrics, Jean Verdier University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), University Paris 13, France.
Huchon C; Department of Gynaecology and Obstetrics, Centre Hospitalier Intercommunal, Poissy, France.
Daraï E; Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), University Pierre and Marie Curie, Institut Universitaire de Cancérologie (IUC), Paris 6, France; INSERM UMR_S_938, University Pierre et Marie Curie, Paris 6, France.
Ballester M; Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), University Pierre and Marie Curie, Institut Universitaire de Cancérologie (IUC), Paris 6, France; INSERM UMR_S_938, University Pierre et Marie Curie, Paris 6, France.
Levêque J; CHU de Rennes, Service de Gynécologie, Hopital Sud, 16 Bd de Bulgarie, 35000 Rennes, France; Université de Rennes 1, France; INSERM 1242, Oncogenesis, Stress and Signaling, CRLC Eugène Marquis, Rennes, France.
Lavoue V; CHU de Rennes, Service de Gynécologie, Hopital Sud, 16 Bd de Bulgarie, 35000 Rennes, France; Université de Rennes 1, France; INSERM 1242, Oncogenesis, Stress and Signaling, CRLC Eugène Marquis, Rennes, France. Electronic address: .
Pokaż więcej
Źródło :
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2017 Nov; Vol. 43 (11), pp. 2135-2142. Date of Electronic Publication: 2017 Aug 09.
Typ publikacji :
Journal Article
MeSH Terms :
Endometrial Neoplasms/*drug therapy
Endometrial Neoplasms/*surgery
Practice Patterns, Physicians'/*statistics & numerical data
Age Factors ; Aged ; Aged, 80 and over ; Case-Control Studies ; Endometrial Neoplasms/pathology ; Female ; Humans ; Lymph Node Excision ; Lymphatic Metastasis ; Neoplasm Grading ; Neoplasm Staging ; Prognosis ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prognostic value of local relapse for patients with endometrial cancer.
Autorzy :
Dabi Y; Department of Obstetrics and Gynaecology, Centre Hospitalier Intercommunal, Créteil, France; Faculté de Médecine de Créteil UPEC - Paris XII, France.
Uzan J; Department of Obstetrics and Gynaecology, Centre Hospitalier Intercommunal, Créteil, France; Faculté de Médecine de Créteil UPEC - Paris XII, France.
Bendifallah S; Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), University Pierre and Marie Curie, Paris 6, Institut Universitaire de Cancérologie (IUC), France.
Ouldamer L; Department of Obstetrics and Gynaecology, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, Tours, France.
Lavoué V; CRLCC Eugène-Marquis, Service de Gynécologie, CHU de Rennes, Université de Rennes 1, France.
Canlorbe G; Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), University Pierre and Marie Curie, Paris 6, Institut Universitaire de Cancérologie (IUC), France.
Raimond E; Department of Obstetrics and Gynaecology, Institute Alix de Champagne University Hospital, Reims, France.
Coutant C; Centre de Lutte Contre le Cancer Georges François Leclerc, Dijon, France.
Graesslin O; Department of Obstetrics and Gynaecology, Institute Alix de Champagne University Hospital, Reims, France.
Collinet P; Department of Obstetrics and Gynecology, Centre Hospitalier Régional Universitaire, Lille, France.
Bricou A; Department of Obstetrics and Gynecology, Jean-Verdier University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), France.
Daraï E; Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), University Pierre and Marie Curie, Paris 6, Institut Universitaire de Cancérologie (IUC), France.
Ballester M; Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), University Pierre and Marie Curie, Paris 6, Institut Universitaire de Cancérologie (IUC), France.
Haddad B; Department of Obstetrics and Gynaecology, Centre Hospitalier Intercommunal, Créteil, France; Faculté de Médecine de Créteil UPEC - Paris XII, France.
Touboul C; Department of Obstetrics and Gynaecology, Centre Hospitalier Intercommunal, Créteil, France; Faculté de Médecine de Créteil UPEC - Paris XII, France. Electronic address: .
Pokaż więcej
Corporate Authors :
Groupe de Recherche FRANCOGYN
Źródło :
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2017 Nov; Vol. 43 (11), pp. 2143-2149. Date of Electronic Publication: 2017 Aug 31.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Endometrial Neoplasms/*pathology
Endometrial Neoplasms/*therapy
Neoplasm Recurrence, Local/*pathology
Aged ; Female ; France ; Humans ; Middle Aged ; Prognosis ; Risk ; Sentinel Lymph Node Biopsy ; Survival Rate
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies